A team led by Yiannis Chatzizisis, MD, PhD, section chief of interventional cardiology at Nebraska Medicine, implanted the Synergy Megatron stent in two women in their early 60s in separate procedures Feb. 11.
The stent, created by Boston Scientific, is designed to fit larger vessels and earned FDA approval in late January.
“The Megatron coronary stent is a paradigm shift in interventional cardiology, as it introduces for the first time the concept of using stents specifically designed for specific parts of heart arteries,” Dr. Chatzizisis told local Omaha station News Radio 1110 KFAB. “This is truly a 21st century precision medicine approach.”
Other health systems will start using the new stent this week, according to KFAB.
More articles on cardiology:
Consider structural racism in health disparity research, editors of heart journal say
5 cardiologists on the move
Virginia hospital opens $2.5M cardiac cath lab
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.